Shedding Light onto Coverage Opportunities for Digital Health Products, Analysis of the Impact of MDR on Clinical & Follow-On Impact on Market Access, all while Continuously Optimizing Strategies to Meet Various Payer Expectations & Successfully Achieve Reimbursement
As medical technology has continued to rapidly evolve in design and complexity, device and diagnostic manufacturing corporations face the challenge of obtaining coverage for innovative products as well as market access with fair pricing in a cost-constrained environment. With member state government payers granting reimbursement solely to products exhibiting the most interesting cost-benefit ratios in the effort of safeguarding public funds all while giving patients access to optimal treatments, the industry must ensure a clear understanding of continuously evolving country-specific frameworks and requirements to gain access with satisfactory rates. In addition, reimbursement professionals increasingly focus on further opportunities to obtain coverage through direct targeting of hospitals and private insurance organizations to bolster return on investment in European markets, for which distinct strategies must be designed and executed.
Currently in the industry’s spotlight, digital health products are rapidly expanding, and raise many questions relevant to reimbursement opportunities and demonstrating value of virtual offerings through traditional clinical evidence generation strategies. Another area of timely and great relevance for medtech professionals is the evolving regulatory framework with the upcoming MDR and IVDR, which strongly impact clinical operations and define new requirements for product safety and efficacy evidence, ultimately also impacting reimbursement and disrupting the overall market access continuum. With such pressing matters affecting manufacturers, the 9th edition of the Q1 EU Medical Device & Diagnostic Reimbursement & Market Access conference will once more delve deep into the practical aspects of overcoming critical challenges and optimizing strategies through a thought mix of engaging and traditional presentation formats, as well as a diverse line-up of speakers from the industry and payer organizations.